Search Results 1131-1140 of 17064 for monoclonal antibody

  1. Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects With Elevated Risk - Mayo Clinic

    Evolocumab is a monoclonal antibody that inhibits proprotein convertase subtilisin-kexin type 9 (PCSK9) and lowers low-density lipoprotein (LDL) cholesterol ...

  2. Publications - Cristina Valencia Sanchez, M.D., Ph.D. - Mayo Clinic

    ... Antibody-Associated Disease. Neurology. 2025 May 27; 104 (10):e213557 Epub 2025 May 05. View PubMed; Thakolwiboon S, Gilligan M, Orozco E, Britton JW, Dubey D ...

  3. A Study To Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC - Mayo Clinic

    History of severe hypersensitivity reactions to monoclonal antibodies, which ... antibody or drug specifically targeting T-cell co-stimulation or ...

  4. Mayo Clinic Q & A - Dr. Sudhir Kushwaha & Dr Richard Daly -...

    I'm Dr. Halena Gazelka. April is Donate Life month. When it comes to organ transplantation, patients with high levels of antibodies, also called highly ...

  5. A study of how current treatments impact the course of relapsed myeloma and the effect of the treatments on the quality-of-life measurements. - Mayo Clinic

    Relapsed MM refractory to at least one IMiD, PI, and anti-CD38 antibody ... Monoclonal protein, Skin changes (POEMS) syndrome. ... Prior or concomitant treatment ...

  6. Publications - Michael P. Fautsch, Ph.D. - Mayo Clinic

    Epub 2008 Aug 21. View PubMed; Ezzat MK, Howell KG, Bahler CK, Beito TG, Loewen N, Poeschla EM, Fautsch MP. Characterization of monoclonal antibodies against ...

  7. A Study To Evaluate The Effect Of Aficamten In Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (OHCM). - Mayo Clinic

    * Current or previous use of drugs known to cause cardiomyopathy (eg, anthracyclines, monoclonal antibodies \[trastuzumab\], alkylating agents ...

  8. A Study to Evaluate APG2575 Combined with Novel Therapeutic Regimens To Treat Subjects with Relapsed or Refractory Multiple Myeloma and Immunoglobulin Light Chain Amyloidosis - Mayo Clinic

    Serum monoclonal protein ≥ 1.0 g/dl by protein electrophoresis;; > 200 mg of monoclonal protein in the urine on 24-hour electrophoresis;; If either serum or ...

  9. Broad Evidence of Systemic Immune Activation in Long Term Survivors of Advanced Ovarian Cancer - Mayo Clinic

    ... antibody responses to folate receptor alpha and will have broad evidence of systemic immune activation. Participation eligibility. Participant eligibility ...

  10. A Study to Evaluate AL101 Monotherapy in Patients with Notch Activated Triple Negative Breast Cancer - Mayo Clinic

    Prior treatment with investigational monoclonal antibody will be reviewed case-by-case by the Sponsor. Receiving chronic systemic steroid therapy (in dosing ...